Renata M. Oballa

3.0k citations

42 papers · 1.8k indexed · h-index 24

Co-authors: Ian Paterson Karl R. Gibson Roger D. Norcross Kevin P. Bateman M. David Percival Jean‐Pierre Falgueyret Deborah A. Nicoll‐Griffith Gregg Wesolowski
Topics: Bone Metabolism and Diseases (13 papers)Protease and Inhibitor Mechanisms (10 papers)Peroxisome Proliferator-Activated Receptors (9 papers)
Cited by: Biotechnology Organic Chemistry Cancer Research
Journals: Angewandte Chemie International Edition Analytical Chemistry Scientific Reports
Partner nations: Canada United States United Kingdom

In The Last Decade

Renata M. Oballa

42 papers receiving 1.8k citations

Peers

Countries citing papers authored by Renata M. Oballa

Since Specialization

Citations

This map shows the geographic impact of Renata M. Oballa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Renata M. Oballa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Renata M. Oballa more than expected).

Fields of papers citing papers by Renata M. Oballa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Renata M. Oballa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Renata M. Oballa. The network helps show where Renata M. Oballa may publish in the future.

Co-authorship network of co-authors of Renata M. Oballa

This figure shows the co-authorship network connecting the top 25 collaborators of Renata M. Oballa. A scholar is included among the top collaborators of Renata M. Oballa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Renata M. Oballa. Renata M. Oballa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dual Glycolate Oxidase/Lactate Dehydrogenase A Inhibitors for Primary Hyperoxaluria 2021 ·ACS Medicinal Chemistry Letters ·(unknown),(unknown),(unknown),Alexandre Caron,(unknown),Jennifer H. Cox,(unknown),(unknown),Aaron H. Graff,Andrew G. King,John Knight,Renata M. Oballa,(unknown),(unknown),(unknown),W. Todd Lowther,David Powell	19
2	Stearoyl-CoA desaturase inhibition blocks formation of hepatitis C virus-induced specialized membranes 2014 ·Scientific Reports ·Rodney K. Lyn,Ragunath Singaravelu,Stacia Kargman,(unknown),Helen M. Chan,Renata M. Oballa,Zheng Huang,Daniel M. Jones,Andrew Ridsdale,Rodney S. Russell,Anthony W. Partridge,John Paul Pezacki	55
3	The discovery of benzenesulfonamide-based potent and selective inhibitors of voltage-gated sodium channel Nav1.7 2014 ·Bioorganic & Medicinal Chemistry Letters ·Shaoyi Sun,Qi Jia,(unknown),(unknown),Zaihui Zhang,Sophia Lin,Rainbow Kwan,(unknown),Sultan Chowdhury,Clint Young,Charles J. Cohen,Renata M. Oballa	17
4	Cathepsin K inhibitors increase distal femoral bone mineral density in rapidly growing rabbits 2013 ·BMC Musculoskeletal Disorders ·Brenda L Pennypacker,Renata M. Oballa,(unknown),Donald B. Kimmel,Le T. Duong	10
5	Discovery of potent and liver-selective stearoyl-CoA desaturase (SCD) inhibitors in an acyclic linker series 2011 ·Bioorganic & Medicinal Chemistry Letters ·Nicolas Lachance,Sébastien Guiral,Zheng Huang,Jean‐Philippe Leclerc,Chun Sing Li,Renata M. Oballa,Yeeman K. Ramtohul,Hao Wang,Jin Wu,Lei Zhang	14
6	Plasma-based approach to measure target engagement for liver-targeting stearoyl-CoA desaturase 1 inhibitors 2011 ·Journal of Lipid Research ·France Landry,Chi‐Chung Chan,Zheng Huang,Grégoire Leclair,Chun Sing Li,Renata M. Oballa,Lei Zhang,Kevin P. Bateman	10
7	Nicotinic acids: Liver-targeted SCD inhibitors with preclinical anti-diabetic efficacy 2011 ·Bioorganic & Medicinal Chemistry Letters ·David Powell,W. Cameron Black,Kelly Bleasby,Chi‐Chung Chan,Denis Deschênes,Marc Gagnon,(unknown),Jocelyne Guay,Sébastien Guiral,Michael J. Hafey,Zheng Huang,Élise Isabel,Yves Leblanc,Angela Styhler,Lijing Xu,Lei Zhang,Renata M. Oballa	15
8	Bicyclic heteroaryl inhibitors of stearoyl-CoA desaturase: From systemic to liver-targeting inhibitors 2011 ·Bioorganic & Medicinal Chemistry Letters ·Yeeman K. Ramtohul,David Powell,Jean‐Philippe Leclerc,Serge Léger,Renata M. Oballa,(unknown),Élise Isabel,Chun Sing Li,Sheldon N. Crane,Joël Robichaud,Jocelyne Guay,Sébastien Guiral,Lei Zhang,Zheng Huang	16
9	Discovery of potent and liver-targeted stearoyl-CoA desaturase (SCD) inhibitors in a bispyrrolidine series 2011 ·Bioorganic & Medicinal Chemistry Letters ·Nicolas Lachance,Yves Gareau,Sébastien Guiral,Zheng Huang,Élise Isabel,Jean‐Philippe Leclerc,Serge Léger,(unknown),Christian Nadeau,Renata M. Oballa,Stéphane G. Ouellet,David Powell,Yeeman K. Ramtohul,Geoffrey K. Tranmer,Thao Trinh,Hao Wang,Lei Zhang	25
10	Conversion of systemically-distributed triazole-based stearoyl-CoA desaturase (SCD) uHTS hits into liver-targeted SCD inhibitors 2011 ·Bioorganic & Medicinal Chemistry Letters ·Jean‐Philippe Leclerc,Jean‐Pierre Falgueyret,Mélina Girardin,Jocelyne Guay,Sébastien Guiral,Zheng Huang,Chun Sing Li,Renata M. Oballa,Yeeman K. Ramtohul,Kathryn Skorey,Paul Tawa,Hao Wang,Lei Zhang	11
11	Biological activity and preclinical efficacy of azetidinyl pyridazines as potent systemically-distributed stearoyl-CoA desaturase inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·Élise Isabel,David Powell,W. Cameron Black,Chi‐Chung Chan,Sheldon N. Crane,Robert J. Gordon,Jocelyne Guay,Sébastien Guiral,Zheng Huang,Joël Robichaud,Kathryn Skorey,Paul Tawa,Lijing Xu,Lei Zhang,Renata M. Oballa	24
12	2-Aryl benzimidazoles: Human SCD1-specific stearoyl coenzyme-A desaturase inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·David Powell,Yeeman K. Ramtohul,(unknown),Renata M. Oballa,Sathesh Bhat,Jean‐Pierre Falgueyret,Sébastien Guiral,Zheng Huang,Kathryn Skorey,Paul Tawa,Lei Zhang	23
13	SAR and optimization of thiazole analogs as potent stearoyl-CoA desaturase inhibitors 2010 ·Bioorganic & Medicinal Chemistry Letters ·Yeeman K. Ramtohul,(unknown),Chi‐Chung Chan,Sheldon N. Crane,Jocelyne Guay,Sébastien Guiral,Zheng Huang,Renata M. Oballa,Lijing Xu,Lei Zhang,Chun Sing Li	31
14	Investigation of ketone warheads as alternatives to the nitrile for preparation of potent and selective cathepsin K inhibitors 2008 ·Bioorganic & Medicinal Chemistry Letters ·Michael J. Boyd,Sheldon N. Crane,Joël Robichaud,John Scheigetz,W. Cameron Black,Nathalie Chauret,Qingping Wang,Frédéric Massé,Renata M. Oballa	23
15	Effect of Cathepsin K Inhibitor Basicity on in Vivo Off-Target Activities 2007 ·Molecular Pharmacology ·Sylvie Desmarais,W. Cameron Black,Renata M. Oballa,Sonia Lamontagne,Denis Riendeau,Paul Tawa,Le T. Duong,Maureen Pickarski,M. David Percival	61
16	MS ^E with mass defect filtering for in vitro and in vivo metabolite identification 2007 ·Rapid Communications in Mass Spectrometry ·Kevin P. Bateman,José Castro‐Perez,Mark Wrona,John P. Shockcor,Kate Yu,Renata M. Oballa,Deborah A. Nicoll‐Griffith	204
17	The stereocontrolled total synthesis of altohyrtin A/spongistatin 1: the AB-spiroacetal segment 2005 ·Organic & Biomolecular Chemistry ·Ian Paterson,Mark J. Coster,David Y.‐K. Chen,Renata M. Oballa,Debra J. Wallace,Roger D. Norcross	37
18	A strategy for identification of drug metabolites from dried blood spots using triple‐quadrupole/linear ion trap hybrid mass spectrometry 2005 ·Rapid Communications in Mass Spectrometry ·Timo Mauriala,Nathalie Chauret,Renata M. Oballa,Deborah A. Nicoll‐Griffith,Kevin P. Bateman	35
19	Total syntheses of the sesquiterpenoids (+)-trans-dracunculifoliol and (+)-4-hydroxyoppositan-7-one 2005 ·Tetrahedron ·Renata M. Oballa,Rebekah Carson,(unknown),(unknown),Joël Robichaud	5
20	Stereocontrolled Total Synthesis of (+)-Altohyrtin A/Spongistatin 1 Financial support was provided by the EPSRC (GR/L41646), Cambridge Commonwealth Trust (Scholarship to M.J.C.), EC (Marie Curie Postdoctoral Fellowship to J.L.A.), DFG (Postdoctoral Fellowship to T.T.), NSERC-Canada (Postdoctoral Fellowship to R.M.O.), Churchill College (Research Fellowship to D.J.W.), Kingapos;s College and Sims Fund, Cambridge (Scholarship to D.Y.K.C.). We also thank Merck and AstraZeneca Pharmaceuticals for generous support, and Dr. Anne Butlin (AZ) and Dr. Nick Bampos (Cambridge) for valuable assistance. 2001 ·Angewandte Chemie International Edition ·Ian Paterson,David Y.‐K. Chen,Mark J. Coster,José Luis Aceña,Jordi Bach,Karl R. Gibson,Linda E. Keown,Renata M. Oballa,Thomas Trieselmann,Debra J. Wallace,(unknown),Roger D. Norcross	94

About Renata M. Oballa

Renata M. Oballa is a scholar working on Cancer Research, Immunology and Allergy and Biotechnology, having authored 42 papers that have together received 1.8k indexed citations. Recurring topics across this work include Bone Metabolism and Diseases (13 papers), Protease and Inhibitor Mechanisms (10 papers) and Peroxisome Proliferator-Activated Receptors (9 papers). The work is most often cited by research in Biotechnology (257 citations), Organic Chemistry (720 citations) and Cancer Research (281 citations). Renata M. Oballa has collaborated with scholars based in Canada, United States and United Kingdom. Frequent co-authors include Ian Paterson, Karl R. Gibson, Roger D. Norcross, Kevin P. Bateman, M. David Percival, Jean‐Pierre Falgueyret, Deborah A. Nicoll‐Griffith, Gregg Wesolowski, W. Cameron Black and Sheldon N. Crane. Their work appears in journals such as Angewandte Chemie International Edition, Analytical Chemistry and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact